Tissue engineering startup Spiderwort raises $17.1 million CAD to move to clinical trials
Spiderwort’s plant-based scaffolding can be used in regenerative medicine and tissue engineering.
Spiderwort’s plant-based scaffolding can be used in regenerative medicine and tissue engineering.
Startup TNT co-founders raising venture fund.
Plus: Judge rules Apple Watch infringed AliveCor’s ECG patent, setting up potential U.S. import ban.
AstraZeneca is one of ACTO’s biggest customers.
The Montréal startup wants to help workers with what keeps them up at night.
Plus: DOT Mind Unlock wins #CollisionConf 2022 startup pitch competition.
After backing nine startups through first fund, Pender Ventures hopes to raise $100 million CAD for Fund II.
Plus: Residents say China used health tracker for crowd control.
DOT can measure people’s brainwave activity using headsets.
Plus: Teladoc Health faces class action lawsuit alleging it misled investors.
Plus: Quebec’s medical records database still only accessible via Internet Explorer.
New York Jets’ guard bets on Montréal-made fitness video game.
Plus: MFine is not fine.
The four recipients operate in the life sciences, cleantech, and digital sectors.
Despite Omicron-related “setbacks,” Think Research sees strong Q1 revenue growth.